Zymar en es it fr

Zymar Brand names, Zymar Analogs

Zymar Brand Names Mixture

  • GyneCure Vaginal Ointment Tandempak 6.5% (Tioconazole + other)
  • GyneCure Vaginal Ovules Tandempak (Tioconazole + other)

Zymar Chemical_Formula


Zymar RX_link


Zymar fda sheet

Zymar FDA

Zymar msds (material safety sheet)

Zymar MSDS

Zymar Synthesis Reference

No information avaliable

Zymar Molecular Weight

375.394 g/mol

Zymar Melting Point

182-185 oC

Zymar H2O Solubility

60 mg/mL (at pH 4)

Zymar State


Zymar LogP


Zymar Dosage Forms

Liquid; Solution; Tablet

Zymar Indication

For the treatment of bronchitis, sinusitis, community-acquired pneumonia, and skin infections (abscesses, wounds) caused by S. pneumoniae, H. influenzae, S. aureus, M. pneumoniae, C. pneumoniae, L. pneumophila, S. pyogenes

Zymar Pharmacology

Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone antibacterial agent for oral or intravenous administration. is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gatifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Zymar Absorption

Well absorbed from the gastrointestinal tract after oral administration with absolute bioavailability of gatifloxacin is 96%

Zymar side effects and Toxicity

No information avaliable

Zymar Patient Information

No information avaliable

Zymar Organisms Affected

Enteric bacteria and other eubacteria